Author:
Tan Shuzhen,Li Dongpei,Zhu Xiao
Funder
National Natural Science Foundation of China
Guangdong Provincial Science and Technology Department
The Public Service Platform of South China Sea for R&D Marine Biomedicine Resources
Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang
Zhanjiang Science and Technology Plan
Group-type” Special Supporting Project for Educational Talents in Universities
Subject
Pharmacology,General Medicine
Reference90 articles.
1. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013
2. Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma;Chevolet;Oncoimmunology,2015
3. Immunotherapy of solid tumor: perspectives on vaccine and cell therapy;Ikeda;Nihon Rinsho,2012
4. Recent perspective on CAR and Fcgamma-CR T cell immunotherapy for cancers: preclinical evidence versus clinical outcomes;Marei;Biochem. Pharmacol.,2019
5. Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors;Panda;JCO Precis Oncol,2017
Cited by
419 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献